UBS Group’s PureTech Health PRTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $345 | Hold |
20
| – | – | ﹤0.01% | 8535 |
|
|
2025
Q1 | $396 | Sell |
20
-1,883
| -99% | -$37.3K | ﹤0.01% | 8477 |
|
|
2024
Q4 | $35.1K | Buy |
1,903
+1,256
| +194% | +$23.2K | ﹤0.01% | 6289 |
|
|
2024
Q3 | $13.3K | Buy |
647
+296
| +84% | +$6.1K | ﹤0.01% | 6382 |
|
|
2024
Q2 | $8.78K | Buy |
351
+331
| +1,655% | +$8.28K | ﹤0.01% | 6623 |
|
|
2024
Q1 | $570 | Hold |
20
| – | – | ﹤0.01% | 7295 |
|
|
2023
Q4 | $564 | Sell |
20
-8
| -29% | -$226 | ﹤0.01% | 7371 |
|
|
2023
Q3 | $644 | Buy |
28
+8
| +40% | +$184 | ﹤0.01% | 7209 |
|
|
2023
Q2 | $570 | Sell |
20
-1
| -5% | -$29 | ﹤0.01% | 7091 |
|
|
2023
Q1 | $609 | Buy |
21
+1
| +5% | +$29 | ﹤0.01% | 7856 |
|
|
2022
Q4 | $638 | Hold |
20
| – | – | ﹤0.01% | 8912 |
|
|
2022
Q3 | $1K | Sell |
20
-349
| -95% | -$17.5K | ﹤0.01% | 8901 |
|
|
2022
Q2 | $7K | Buy |
369
+349
| +1,745% | +$6.62K | ﹤0.01% | 7475 |
|
|
2022
Q1 | $1K | Hold |
20
| – | – | ﹤0.01% | 8845 |
|
|
2021
Q4 | $1K | Hold |
20
| – | – | ﹤0.01% | 8883 |
|
|
2021
Q3 | $1K | Sell |
20
-43
| -68% | -$2.15K | ﹤0.01% | 8068 |
|
|
2021
Q2 | $3K | Sell |
63
-66
| -51% | -$3.14K | ﹤0.01% | 7722 |
|
|
2021
Q1 | $7K | Sell |
129
-96
| -43% | -$5.21K | ﹤0.01% | 7125 |
|
|
2020
Q4 | $12K | Buy |
+225
| New | +$12K | ﹤0.01% | 6328 |
|